Klinikum Der Landeshauptstadt Stuttgart gKAöR — Clinical Trial Site

89 Registered trials

53 Currently recruiting

Organisation

Klinikum Der Landeshauptstadt Stuttgart gKAöR

Location

Stuttgart, Germany

Identifier

ORG-100009355

Address

Kriegsbergstrasse 62, Mitte, 70174, Germany

Departments

#1201: Pädiatrie 5 (Onkologie, Hämatologie, Immunologie)
2102: Klinik für Nuklearmedizin
276001: Paediatrie 5. Onkologie, Hämatologie, Immuno
Augenklinik, Kopf- und Neurozentrum
Clinic for Haematology, Oncology, Stem Cell Transplantation and Palliative Medicine
Clinic for Hematology, Oncology, Stem Cell Transplantation and Palliative Medicine
Clinic for Kidney, Hypertension and Autoimmune Diseases
Department of Radiation and Oncology
Fachabteilungsbereich Hämatologie und internistische Onkologie
Frauenklinik
Gynecology and Obstetrics
Hämatologie, Onkologie und Palliativmedizin
Hämatologie,Onkologie, Palliativmedizin
Hämatologie/Onkologie
Hämostaseologie und Stammzelltransplantation
Hematology
Interdisziplinäre internistische Onkologie, Hämatologie und Palliativmedizin
Katharinenhospital, Klinik für Hämatologie, Onkologie, Stammzelltransplantation und Palliativmedizin
Kinder und Jugendmedizin
Klinik f. Hämatologie, Onkologie u. Palliativmedizin
Klinik fuer Urologie
Klinik für Endokrinologie, Diabetologie und Geriatrie
Klinik für Gastroenterologie, gastrointestinale Onkologie, Hepatologie, Infektiologie u. Pneumologie
Klinik für Hämatologie, Onkologie und Palliativmedizin
Klinik für Hämatologie, Onkologie und Palliativmedizin Stuttgart Cancer Center
Klinik für Hämatologie, Onkologie und Palliativmedizin Stuttgart Cancer Center/Tumorzentrum Eva Ma
Klinik für Hämatologie, Onkologie und Palliativmedizin, Stuttgart Cancer Center
Klinik für Hämatologie, Onkologie, Stammzelltransplantation und Palliativmedizin
Klinik für Hämatologie, Onkologie, Stammzelltransplantation und Palliativmedizin
Klinik für Hämatologie, Onkologie, Stuttgart Cancer Center (SCC)
Klinik für Neurologie
Klinik für Onkologie
Klinik für Pneumologie und Beatmungsmedizin
Klinik für Pneumologie und Beatmungstherapie
Klinik für Strahlentherapie und Radioonkologie
Klinik für Urologie und Transplantationschirurgie
Klinikum Stuttgart - Katharinenhospital, Innere Medizin
Neurologische Klinik
Olgahospital Pädiatrie 5
Olgahospital, Pädiatrie 5 (Onkologie, Hämatologie, Immunologie)
Olgasptial / Frauenklinik
Oncology Department
Oncology, Hematology and Immunology
Ophthalmology
Pädiatrie 5
Pädiatrie 5 (Onkologie, Hämatologie und Immunologie)
Pädiatrie 5 (Onkologie, Hämatologie, Immunologie)
Paediatrie3–ZentrumfuerAngeboreneHerzfehlerStuttgart,PaediatrischeIntensivmedizin,Pneumologie,Allerg
Paedriatrics, Department of Oncology and Hematology
Pediatric hematology/oncology
Pediatrics 5 (hematology, oncology, immunology)
Strahlentherapie und Radioonkologie
Stuttgart Cancer Center Mitte
Stuttgart Cancer Center Standort Mitte (Katharinenhospital)
Stuttgart Cancer Center, Tumorzentrum Eva-Mayr-Stihl
Tumorzentrum Eva Mayr-Stihl
Tumorzentrum Eva-Mayr-Stihl
Urologische Klinik
Zentrum fuer Dermatologie, Phlebologie und Allergologie
Zentrum für Kinder- und Jugendmedizin
Zentrum für Kinder- und Jugendmedizin Pädiatrie 5 (Onkologie, Hämatologie, Immunologie)
Zentrum für Kinder-, Jugend und Frauenmedizin Pädiatrie 5 (Onkologie, Hämatologie; Immunologie)
Zentrum für Kinder-, Jugend- und Frauenmedizin

Clinical trials at this site (89)

Search interface

Randomised efficacy and safety clinical trial of PQ Birch in subjects with seasonal allergic rhinitis and/or rhinoconjunctivitis induced by … Pending

2023-507427-28-00 seasonal allergic rhinitis and/or rhinoconjunctivitis 5
SIOP PNET 5 medulloblastoma Pending

2024-513724-42-00 Medulloblastoma 10
Comparison of neurocognitive outcome in two standard regimen for treatment of low-risk medulloblastoma (COGNITO-MB) Pending

2024-517133-40-00 newly diagnosed, non-metastatic, SHH-activated, TP53-wt 5
Prospective multicenter clinical trial for risk estimation and treatment stratification in low and intermediate risk neuroblastoma patients … Pending

2024-517295-37-00 low and intermediate risk neuroblastoma 5
Study to assess the efficacy and safety of Rina-S plus standard of care compared to standard of care for maintenance treatment of participan… Pending

2025-522167-15-00 Ovarian Cancer Platinum-Sensitive Ovarian Cancer (PSOC) 5
A single-arm phase II-study to confirm efficacy and feasibility of tarlatamab treatment in patients with extensive stage small-cell lung can… Recruiting

2025-522437-65-00 small-cell lung cancer 4 2026-03-06
A study to investigate the effect of adding bleximenib to standard-of-care treatment with intensive chemotherapy in patients with a specific… Recruiting

2025-522767-15-00 Acute Myeloid Leukemia 5 2026-01-27
STOP-PKD: SGLT2-inhibition to improve Prognosis in Polycystic Kidney Disease Recruiting

2025-521276-59-00 Autosomal dominant polycystic kidney disease (ADPKD) 5 2025-12-16
Study on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-… Recruiting

2025-520982-39-00 Philadelphia Chromosome Positive or ABL-class Philadelp 5 2025-12-09
Dato-DXd plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Previously Treated la/mUC. Recruiting

2024-516906-47-00 Locally Advanced or Metastatic Urothelial Carcinoma 10 2025-11-28
A study to investigate the effect of adding venetoclax to treatment with ivosidenib and azacitidine in patients with acute myeloid leukemia … Recruiting

2024-512753-24-00 Acute Myeloid Leukemia (AML) 5 2025-08-05
A study investigating the effect of adding revumenib to treatment with venetoclax + azacitidine in patients with acute myeloid leukemia (AML… Recruiting

2024-512733-32-00 Acute Myeloid Leukemia (AML) 5 2025-03-31
A randomized phase III trial assessing iberdomide versus iberdomide plus isatuximab maintenance therapy post autologous hematopoietic stem-c… Recruiting

2023-507402-13-00 Multiple myeloma 5 2024-04-03
Treatment of infants under one year with acute lymphoblastic leukemia according to the Interfant-21 protocol Recruiting

2022-502503-30-00 Acute lymphoblastic leukemia 5 2022-12-15
Evaluation of Niraparib alone compared to the combination of Niraparib and Bevacizumab in patients receiving chemotherapy for newly diagnose… Recruiting

2024-516066-11-00 Patients with newly diagnosed, histologically confirmed 5 2022-08-31
A PROSPECTIVE, OPEN-LABEL, MULTICENTER, RANDOMIZED, PHASE 3 TRIAL OF ACALABRUTINIB, OBINUTUZUMAB AND VENETOCLAX (GAVE) COMPARED TO OBINUTUZU… Recruiting

2023-506414-46-00 High risk patients defined as having at least one of th 5 2022-04-22
Pembro-FLASH Recruiting

2022-501458-13-01 Advanced Stage of Classic Hodgkin Lymphoma 4 2026-04-29
A clinical trial of sacituzumab tirumotecan to treat urothelial cancer (MK-2870-031) Recruiting

2024-520014-22-00 Locally advanced/metastatic urothelial carcinoma 5 2026-04-22
A trial to learn how effective and safe datopotamab deruxtecan (Dato-DXd) is compared to docetaxel and how well Dato-DXd works in adults wit… Recruiting

2024-520101-39-00 TROP2 NMR-positive advanced or metastatic non-squamous 5 2026-04-01
A clinical trial to learn about the effects of AMO959 given with AAA617 and an androgen receptor pathway inhibitor (ARPI) in adults with PSM… Recruiting

2025-521859-23-00 PSMA-positive mCRPC with prior exposure to at least one 9 2026-03-31
Thrombolysis with Tenecteplase for Acute Ischemic Stroke in Patients taking Direct Oral Anticoagulants Recruiting

2025-521762-99-00 acute ischemic stroke 5 2026-03-09
Efficacy and Safety of Lisocabtagene Maraleucel (liso-cel) as First-Line Therapy in Adults with Transplant-Ineligible Primary Central Nervou… Recruiting

2025-521144-38-00 Primary Central Nervous System Lymphoma 4 2025-12-23
A clinical study of MK-1084 and other treatments for lung cancer (MK-1084-007) Recruiting

2024-514500-14-00 Participants with KRAS G12C-Mutant, Advanced or Metasta 5 2025-12-15
A Phase II Randomized Clinical Trial Comparing Two Cycles Versus Four Cycles of Combination Therapy with Cetuximab, Avelumab, Cisplatin, and… Recruiting

2025-521738-27-00 Recurrent Metastatic Head and Neck Cancer 4 2025-12-15